NSF, IDMA sign MoU to improve cGMP framework for India’s nutra industry

Bristol’s $1.5B Orbital buyout extends ‘in vivo’ cell therapy deal streak

DRRA1 hour ago 0

AstraZeneca Expands US Manufacturing Footprint by Increasing Virginia Facility Investment to $4.5 Billion

DRRA2 hours ago 0

Navigating Pharmacy Models and Regulatory Pitfalls When Launching Direct-To-Consumer Programs

DRRA3 hours ago 0

Advances in Digitalization and Automation of Aseptic Processing

DRRA3 hours ago 0